Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

When Jeffrey Ubben Likes A Stock Like Agrium Inc. (AGU), You Should Pay Attention

Page 1 of 2

In a recent 13D filing with the Securities and Exchange Commission, Jeffrey Ubben’s ValueAct Capital disclosed a 6.8% ownership stake in Agrium Inc. (NYSE:AGU), amounting to 9.72 million shares. ValueAct Capital increased its overall position in the global leader in agricultural products and services by about 1.76 million shares, or 22% since its most recent 13F filing.


We follow hedge funds like ValueAct Capital because our research has shown that their stock picks historically managed to generate alpha even though the filings are up to 45-days delayed. We used a 60-day delay in our back tests to be on the safe side and our research showed that the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Total Return Index by an average of 95 basis points per month between 1999 and 2012. After adjusting for risk, our calculations revealed that these stocks’ monthly alpha was 80 basis points. We have also been sharing and tracking the performance of these stocks since the end of August 2012, during which time they have returned 142%, outperforming the S&P 500 ETF by nearly 83 percentage points (see more details here).

ValueAct Capital is an activist hedge fund firm founded by its current Chief Executive and Chief Investment Officer, Jeffrey Ubben, in 2000. Ubben, unlike most of the activists who pursue a confrontational approach, is a quiet instigator who aims at creating value by collaborating with the board and management of the companies he invests in. The San-Francisco-based activist hedge fund firm is behind some of the world’s most notorious corporate overhauls and has attempted to push for changes at around 75 firms since its inception. ValueAct Capital has also delivered quite strong returns throughout its existence, generating an annualized return of 17% net-of-fees. The latest 13F filing displays that the value of the public equity portfolio managed by Ubben equals $18.09 billion. In the following article, we are going to start with a discussion on the most recent move made by Ubben in Agrium Inc. (NYSE:AGU), followed by briefly running through two other fresh picks of ValueAct Capital, which represent the following companies: Precision Castparts Corp. (NYSE:PCP) and WESCO International Inc. (NYSE:WCC).

Jeffrey Ubben
Jeffrey Ubben
ValueAct Capital

Agrium Inc. (NYSE:AGU) is a major global crop input retail supplier of agricultural products and services. In addition to that, the company produces and markets the three major agricultural nutrients (i.e. nitrogen, phosphorus, and potassium), making it a leading wholesale producer of this kind in the world. The shares of Agrium have increased by over 9% year-to-date and might keep rising as the outlook of the company remains relatively strong. Agrium has been growing at a high pace lately through a combination of organic growth, which is the true growth for the core of the company, and acquisitions. Currently, there are a few short-term challenges for Agrium that might have already been priced into or might still slightly affect the company. For instance, nitrogen prices are expected to decrease due to the uncertainty regarding Chinese export supplies, so Agrium might suffer a bit from this environment. Nevertheless, despite its current challenges, Agrium is expected to benefit from the healthy trends in the agriculture and crop input markets in the long-term. Precisely, it is anticipated that the demand for crop protection products will rise, which will benefit the company’s retail business.

Let’s briefly discuss the financial performance of the company during its fiscal first quarter of the year. Considering the fact that the delayed start to the spring season in the U.S. affected the financial performance of Agrium, the company still managed to deliver quite strong financial results. Agrium reported net earnings of $14 million for the quarter, significantly higher than the $3 million figure posted during the same period a year ago. However, the company posted revenues of $2.87 billion, which marks a decrease of 7% year-over-year. The drop was triggered by a double-digit drop in wholesale sales. At the same time, Agrium’s Board of Directors announced an increase in its cash dividend by 12% to $3.50 per common share on an annualized basis, a yield of 3.38% at present, which signals that the company is in solid financial health despite facing some short-term challenges. The hedge fund founded by D. E. Shaw is among the largest shareholders in Agrium Inc. (NYSE:AGU) within our database, owning 1.27 million shares valued at $132.24 million as of March 31, 2015.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!